Lenvima plus Keytruda New Combination Approved for Advanced Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 38
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 10
Results: 19
1
2
Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumor.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 38
- Publication type:
- Article
3
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 37
- Publication type:
- Article
4
Brukinsa Approved for Marginal-Zone Lymphoma and for Waldenström's Macroglobulinemia.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 37
- Publication type:
- Article
5
Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 36
- Publication type:
- Article
6
Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 36
- Publication type:
- Article
7
Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 36
- Publication type:
- Article
8
Adjuvant Nivolumab Prolongs Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 35
- Publication type:
- Article
9
The Political Raid on Future Cures: The Democratic price controls on drugs would be a historic tragedy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 34
- Publication type:
- Article
10
Biden's Price Controls Will Make Good Health More Expensive: Pharmaceutical innovation will suffer and drugs that could save your life may not reach the market.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 33
- By:
- Publication type:
- Article
11
Doctors Join the Climate Lobby: Don't they know that poverty kills far more people than heat does?
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 32
- Publication type:
- Article
12
Select Ongoing Trials Currently Enrolling Patients with Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 28
- Publication type:
- Article
13
Why Quality Documentation Matters.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 26
- By:
- Publication type:
- Article
14
5-Year Follow-Up Study Confirms Safety and Efficacy of Trastuzumab Biosimilar in Patients with HER2-Positive Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 24
- By:
- Publication type:
- Article
15
Role of Radiology in Intrahepatic Cholangiocarcinoma Addressed at 2 Interventional Oncology and Radiology Meetings.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 20
- By:
- Publication type:
- Article
16
Lisaftoclax, a Novel BCL-2 Inhibitor, Shows Promise in Relapsed or Refractory CLL and SLL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 8
- By:
- Publication type:
- Article
17
Aspacytarabine Safe and Effective in Patients with AML Unfit for Intensive Chemotherapy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 1
- By:
- Publication type:
- Article
18
The Impact of New Drug Compounding Standards on Your Practice.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 1
- By:
- Publication type:
- Article
19
Olaparib Prolongs Survival in Patients with Early-Stage Breast Cancer and BRCA Mutation.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 1
- By:
- Publication type:
- Article